Adverum Biotechnologies Retained Earnings (Accumulated Deficit) 2013-2024 | ADVM
Adverum Biotechnologies retained earnings (accumulated deficit) from 2013 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.